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Most stromal corneal dystrophies are associated with aggregation and deposition of the mutated 
transforming growth factor-β induced protein (TGFβIp). The 4th_FAS1 domain of TGFβIp harbors ~80% 
of the mutations that forms amyloidogenic and non-amyloidogenic aggregates. To understand the 
mechanism of aggregation and the differences between the amyloidogenic and non-amyloidogenic 
phenotypes, we expressed the 4th_FAS1 domains of TGFβIp carrying the mutations R555W (non-
amyloidogenic) and H572R (amyloidogenic) along with the wild-type (WT). R555W was more 
susceptible to acidic pH compared to H572R and displayed varying chemical stabilities with 
decreasing pH. Thermal denaturation studies at acidic pH showed that while WT did not undergo 
any conformational transition, the mutants exhibited a clear pH-dependent irreversible conversion 
from αβ conformation to β-sheet oligomers. The β-oligomers of both mutants were stable at 
physiological temperature and pH. Electron microscopy and dynamic light scattering studies showed 
that β-oligomers of H572R were larger compared to R555W. The β-oligomers of both mutants were 
cytotoxic to primary human corneal stromal fibroblast (pHCSF) cells. The β-oligomers of both mutants 
exhibit variations in their morphologies, sizes, thermal and chemical stabilities, aggregation patterns 
and cytotoxicities.
Corneal Dystrophies are inherited protein aggregation disorders characterized by the deposition of misfolded 
proteins aggregates in various layers of the cornea1–3. Most dystrophies in the corneal stromal region are asso-
ciated with the mutations in the transforming growth factor β -induced protein (TGFβ Ip). TGFβ Ip aggregation 
and deposition occurs only in the cornea, though it is present in abundance in various connective tissues4–7. The 
mature TGFβ Ip, a 660aa protein has an N-terminal cysteine-rich EMILIN-like (EMI) domain, four fascicilin-like 
(FAS1) domains and an integrin-binding RGD motif at the C-terminus8. TGFβ Ip-associated corneal dystrophies 
are phenotypically heterogeneous, inherited in an autosomal dominant manner1,9,10 and are classified as lattice, 
granular, combined lattice and granular, Reis-Buckler and Thiel-Behnke corneal dystrophies1,2,11,12. So far, 64 
single amino acid mutations associated with distinct phenotypes have been reported4,13,14. Among the four FAS1 
domains of TGFβ Ip, the 1st and 4th FAS1 domains carry the disease related mutations, with ~80% of the muta-
tions residing in the 4th_FAS1 domain11. In lattice corneal dystrophies (LCD), the protein aggregates appear as 
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lattice lines or amyloid fibrils (amyloidogenic). In granular corneal dystrophies (GCD), they appear as granular, 
non-amyloidogenic deposits11–16. Both phenotypes display significant differences in morphology, aggregation and 
tinctorial properties. However, the mechanisms adopted by these phenotypes in forming highly distinct ultras-
tructures, remains to be elucidated.
It has been reported that the ability to form highly ordered aggregates such as amyloids, resides within the 
polypeptide chains rather than the whole protein17. Hence, we chose to explore the crucial 4th_FAS1 domain 
(135aa) as a representative of the full-length TGFβ Ip. Bioinformatics analyses of the aggregation propensities 
of various regions of TGFβ Ip have also shown that the 4th_FAS1 domain harbors regions of high aggregation 
propensities18,19. Also, homology-based modelling studies have shown that the 4th_FAS1 domain displays the 
properties of the full-length TGFβ Ip20.
In our study, we aim to delineate the differences between the amyloidogenic and the non-amyloidogenic 
mutants and between the mutants and wild-type (WT) TGFβ Ip to explain the physiological variations exhibited 
by these phenotypes. We had previously reported the cloning, expression and purification of the 4th_FAS1 domain 
of four TGFβ Ip mutants21. Our studies indicated that under physiological pH, the mutants are more stable than 
the WT. Here, we chose to examine the effects of factors like temperature and pH on the properties of the 4th_
FAS1 domains of TGFβ Ip harboring mutations of the amyloidogenic and non-amyloidogenic phenotypes. The 
amyloidogenic H572R (LCDI/IIIA), discovered in Thai22 and Chilean populations23 with ages of onset ranging 
around mid-twenties, is characterized by central sub-epithelial needle-like lattice lines and polymorphic anterior 
stromal opacities. The highly ubiquitous non-amyloidogenic R555W (GCDI/II)24–26 appears as rod shaped or 
granular bodies with sharp borders found in the central corneal stroma27,28. We aimed to examine the effects of 
these charge modifying mutations on the domains, their aggregation, their sensitivity to pH and temperature.
Aggregating proteins are found to be more susceptible to acidic pH and increase in temperature29,30. Even in 
TGFβ Ip, it has been shown that the R124H mutation induces localization of TGFβ Ip to lysosomes with an acidic 
environment31. In the present study, we have investigated the effects of acidic pH, denaturants and temperature 
on the secondary structure and conformational stability of the domains. The cytotoxicities of the aggregates were 
also studied in primary human corneal stromal fibroblasts (pHCSF).
Results
Effects of biochemical and biophysical factors on WT and mutants. The native 4th_FAS1 domain 
(Fig. 1a) of TGFβ Ip (Genbank_ID-NM_000358; Protein_ID:-NP_000349) and the mutants R555W and H572R 
were cloned and purified (Fig. 1b) as described previously21. The estimated pI values of the WT, R555W and 
H572R domains were 6.53, 6.32 and 6.65 respectively. The amino acid substitutions (R→ W and H→ R) were 
associated with changes in charge and hydrophobicity as listed in the table (Table 1).
Effect of pH on the secondary structures of the WT and mutants. The CD spectra for the WT and 
the mutants at pH 7 (Fig. 1c–e) showed negative minima in the n – π * region (222 nm) and a weak shoulder 
at the π –π * region (207 nm) corresponding to their mixed α -helical and β -sheet conformations. Under acidic 
conditions, there were discernible differences between the WT and mutants in their secondary structure. The 
non-amyloidogenic R555W was more sensitive to pH compared to the WT and amyloidogenic H572R. The WT 
(Fig. 1c) and H572R (Fig. 1e) remained unchanged under neutral and acidic pH. The R555W mutant displayed 
an increase in the CD intensity at 222 nm and 207 nm with decrease in pH (Fig. 1d). CD intensities at 222 nm at 
varying pH values (Fig. 1f) showed that R555W, was more sensitive to pH and the pH-response of H572R was 
similar to the WT protein. We also incubated the mutants in acidic pH for 1 week and followed their aggregation/
oligomerization by ThT fluorescence (Supplementary Fig. S1). However, no significant conversion was observed 
as seen from the corresponding CD spectra for WT and H572R. At pH 2.75, R555W showed a partial conversion 
to β -sheet. Compared to the amyloid fibril peptide pN622K, almost no increase in fluorescence was observed for 
WT and R555W. The slight increase in fluorescence corresponding to pH 2.75 and pH 3.25 for H572R did not 
show a corresponding conversion in the CD spectra.
Effect pH on thermal denaturation of WT and mutants. Conformational transition of the domains 
undergoing thermal denaturation was examined by heating them from 20 °C to 70 °C, at neutral and acidic pH 
conditions. At pH 7 and pH 8, for both the mutants and the WT, no well-defined transition was observed with 
increasing temperatures (Fig. 2a–f). For both the mutants, the amplitude of the negative minima at 222 nm 
decreased upon heating (Fig. 2c–f) and a weak hysteresis was observed when cooled. With acidic pH, while the 
WT showed no apparent changes in the secondary structure with increasing temperature (Fig. 3a–c), both the 
mutants displayed a clear transition from monomeric α /β -structure to β -sheet (Fig. 3d–i). Single wavelength 
scan at 222 nm indicated a clear sigmoidal transition for both mutants under acidic conditions when compared to 
the WT, which was unperturbed by the changes in pH and temperature (Fig. 4a–e). Thermal denaturation exper-
iments were also done by heating the domains from 20 °C to 90 °C (Supplementary Fig. S2). Though previous 
studies have observed denaturation of WT above 60 °C 32, we did not observe any conformational transitions to 
β -sheet even after heating to 90 °C. The mid-point of the normalized sigmoidal curve defines the transition tem-
perature (Tt) wherein the conversion of a monomeric α /β -structure to the β -structured oligomers was observed. 
The transition for the domains at different pH conditions was similar to the samples heated to 70 °C and the Tt lied 
between 35–58 °C. Hence all the subsequent thermal denaturation experiments were performed by heating the 
domains upto 70 °C. The non-amyloidogenic R555W showed a marked sensitivity to pH and displayed a higher 
thermal instability compared to the H572R. Though H572R mutant displayed a clear pH-dependent conversion 
to β -structure when heated, the Tt was higher than R555W. A difference in Tt of 5–12 °C is observed at various 
pH conditions. Mild precipitation was observed in the samples after heating, which correlates with the change in 
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intensities observed in the CD spectra. When the concentration of the sample was increased (from 0.6 mg/ml to 
1.2 mg/ml~75 μM), the turbidity and precipitation increases.
Urea denaturation of non-amyloidogenic R555W. The tryptophan residue in R555W allowed us to 
measure the emission fluorescence. Examination of the emission fluorescence at ~332 nm of R555W in acidic pH 
showed a significant decrease in emission intensity with decreasing pH, however the emission maxima remained 
unchanged (Fig. 5a). To obtain a better insight into the effect of pH on R555W, we monitored the urea-induced 
unfolding of R555W. Increasing the urea concentration progressively shifts the emission maxima (~332 nm) to 
longer wavelengths (~352 nm), suggesting a clear transition from folded to unfolded conformations (5b–e). To 
confirm refolding of unfolded R555W, the unfolded protein at different pH conditions (pH 3.0, pH 4.5, pH 5.5 
and pH 7.0) was diluted appropriately and emission spectra were recorded. The emission maxima (λ max) plot-
ted with the unfolded and refolded domains were superimposable (Supplementary Fig. S3). (Fig. 5b–e). A clear 
reversal in fluorescence maxima from ~352 nm to ~332 nm was observed thereby allowing us to estimate the 
thermodynamic stability of the mutant protein in various pH. Figure 5f–i shows urea denaturation curves plotted 
as ‘fraction unfolded (yU) vs increasing urea concentrations’ as monitored by the changes in emission maxima 
Figure 1. Biochemical and biophysical properties of the native 4th_FAS1 domains of the wild-type and 
mutant TGFβIp. (a) Schematic representation of the domain arrangement and boundaries of the full-length 
TGFβ Ip and 4th_FAS1 domains of the wild-type, non-amyloidogenic (R555W) and amyloidogenic (H572R) 
mutants used in the study. (b) SDS-PAGE gel showing the purified fractions of the 4th_FAS1 domains of the 
WT, R555W and H572R mutants. (c–e) Far UV CD spectra of the 4th_FAS1 domains of WT (d), R555W (e) and 
H572R (f) incubated for 16 hours at acidic pH conditions (pH 3, 4.5, 5.5 and 7). The R555W mutant displayed 
clear changes in the CD spectra at 222 nm and 207 nm with decrease in pH (f). The CD intensity at 222 nm 
decreased with decrease in pH confirming the unfolding of the secondary structures. The CD spectra for the 
WT (c) and H572R (e) mutant remained almost unchanged. Plotting the intensities at 222 nm at varying pH 
(g) showed that the non-amyloidogenic phenotype, R555W, was more sensitive to pH and the amyloidogenic 
phenotype, H572R, remained more stable to pH changes at room temperature.
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(Δλ max) at various pH values (Supplementary Fig. S3) for the R555W mutant. The thermodynamic parameters 
derived from urea denaturation are shown in the table (Table 2). A significant decrease in free energy of unfold-
ing from 13.8 ± 0.8 kJ/mole to 7.108 ± 1.5 kJ/mole was observed from pH 7.0 to pH 4.5 for the R555W mutant. 
However, for the H572R mutant, fluorescence studies could not be performed because of the absence of a tryp-
tophan residue.
Characterization of the β-oligomers of amyloidogenic and non-amyloidogenic mutants. The 
amyloidogenic and non-amyloidogenic mutants displayed a clear transition to an all β -sheet conformation when 
heated under acidic conditions. Conversion to an all β -sheet conformation could indicate β -oligomer forma-
tion17. A detailed investigation of the β -oligomers from two mutants was therefore performed to validate and 
characterize the proposed β -oligomers.
Confirmation of β-oligomers formed by the mutants and characterization of the β-oligomers by 
TEM and DLS. TEM examination of the β -oligomers revealed that while no particles were visible for the WT 
(data not shown), both the mutants displayed particles validating our proposal. The β -oligomers of the H572R 
and R555W displayed varying sizes and morphologies (Fig. 6a,b). The β -oligomers of the non-amyloidogenic 
R555W were homogeneous, displayed smoother edges and measured ~4–8 nm (mean diameter ~5.1 ± 1.79 nm) 
(Fig. 6a). The β -oligomers of the amyloidogenic H572R were more heterogeneous, displayed rugged edges and 
were larger, measuring 10–40 nm (mean diameter ~19.1 ± 4.9 nm) (Fig. 6b). The β -oligomers formed from the 
amyloidogenic and the non-amyloidogenic phenotypes are distinctly different from each other.
Dynamic light scattering (DLS) allows the examination of apparent hydrodynamic radius (RH) of a protein in 
solution33,34. DLS analysis on the β -oligomers prepared under acidic conditions show that H572R β -oligomers 
exhibit large variations in their RH (~89.95 nm|pH 3.0, ~69 nm|pH 4.5 and ~155 nm|pH 5.5), while R555W β -oligomers 
are more uniform and almost similar across various acidic pH conditions (~39.58 nm|pH 3.0, ~51.9 nm|pH 4.5  
and ~68.2 nm|pH 5.5). The distribution curves from the % intensity plots also show the homogeneity of the 
non-amyloidogenic R555W, and relative heterogeneity of the amyloidogenic H572R. This is in conjunc-
tion with the results obtained from TEM, where we see more homogenous and smaller β -oligomers from the 
non-amyloidogenic R555W mutant and heterogeneous and relatively larger β -oligomers from the amyloidogenic 
H572R mutant.
The β-oligomers of the amyloidogenic H572R shows stronger binding to Thioflavin T 
(ThT). Amyloid fibrils bind to the dye ThT and display an emission fluorescence at 485 nm35,36. In Alzheimer’s 
disease, ThT binds to Aβ -oligomers themselves, and has been proposed for early diagnosis37. We wanted to test if 
the TGFβ Ip β -oligomers bind to ThT. The amyloid forming TGFβ Ip peptide pN622K (pN622K611–633) displayed 
a high fluorescence intensity when bound to ThT (Fig. 6c). The fluorescence displayed by WT was comparable to 
the background fluorescence. Relatively, the β -oligomers of H572R showed significant fluorescence on binding to 
ThT (**P < 0.01) and atleast ~3 times more fluorescence compared to R555W. While the fluorescence intensities 
were much lower compared to the fibril forming peptide, it was significant that the β -oligomers of the amyloido-
genic H572R were able to bind to ThT and this could aid further characterization of the β -oligomers.
The mutants display differences in their ‘aggregation hotspots’. To determine the regions with 
high aggregation propensities or ‘aggregation hotspots’ within the mutants and the β -oligomers, the domains 
were digested with trypsin and the resulting peptides were examined using LC-MS/MS. The peptide map gen-
erated (Supplementary data) following the insilico trypsin digestion displayed a series of peptides (Fig. 6d) 
formed following trypsin digestion. We aimed to identify the regions that were probably buried within the 
β -oligomers and hence resisted trypsin digestion. For WT, three short peptides (549ALPPR553, 591SLQGDK596 
603NNVVSVNK610) were not detectable after tryptic digestions. For R555W, two short peptides (558LLGDAK563, 
591SLQGDK596 were absent. However, for the H572R, peptides in the region E611-L632 were not observed in 
addition to a short peptide (591SLQGDK596) that was absent in the WT and R555W. Mapping the generated pep-
tides to the 4th_FAS1 domain displayed interesting results (Fig. 6e). The entire C-terminal region encompassing 
the residues 603NNVVSVNK610 and 611EPVAEPDIMATNGVVHVITNVL632 peptides was absent in the H572R 
native protein and β -oligomers. This region was intact in WT and R555W. A long stretch of residues between 
E534 and K563 containing the peptides 534EGVYTVFAPTNEAFR548, 549ALPPR553, 554EWSR557, 558LLGDAK563 was 
not observed in R555W β -oligomers. The peptide 591SLQGDK596 was absent in all the proteins. The segment 
WT R555W H572R
Charge of the mutation – R ( + 1) → W(0)
H (0) → R(+1) (at pH 7.0)
H (+1) → R(+1) (at pH < 6.0)
Net Charge (at pH 7.0) −0.6 − 1.6 0.2
Net Charge (at pH 5.5) 1.9 0.9 2.0
Change in hydrophobicity due to the mutation (17) – 3.95 → − 2.13 (at pH 7.0 and pH < 6.0)
0.64 → 3.95 (at pH 7.0)
2.87 → 3.95 (pH < 6.0)
Table 1.  Effects of mutation on the charge and hydrophobicity. The change in the individual charges and 
overall net charge in the mutants. The change in hydrophobicities were calculated using the equation described 
previously (17).
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549ALPPR553 was absent in H572R β -oligomers. The β -oligomers of R555W, displayed a region extending between 
E534 and A562 that could possibly be buried. It is interesting to note that the mutation R555W resides within this 
region. The β -oligomers of H572R did not reveal such a region within the domain. It is likely that different regions 
of the 4th_FAS1 domain may be involved in the formation and stabilization of these β -oligomers.
The β-oligomers remained stable at physiological conditions. For studying the thermal stability 
of the β -oligomers of the R555W (Fig. 7a,b) and H572R (Fig. 7c,d) the mutant domains at pH 5.5 were heated 
to 70 °C and cooled back to 20 °C. The β -oligomers remained in their β -sheet conformation at 20 °C showing 
no reversibility to the native α /β -conformation. To test their stabilities at physiological pH, the β -oligomers 
formed at pH 5.5 were reconstituted to pH 7 and examined (Fig. 7e,f). The samples were also incubated for 4 
weeks at pH 7 and the CD spectra were recorded. In both cases, the β -oligomers remained in their stable β -sheet 
Figure 2. Thermal denaturation of the 4th_FAS1 domains of the WT and mutants at neutral and basic 
pH. (a,b) Far UV CD spectra of the 4th_FAS1 domain of WT at pH 7.0 and pH 8.0 before heating (black), after 
heating to 70 °C (red) and cooling back to 20 °C (blue). (c,d) Far UV CD spectra of the 4th_FAS1 domains of 
R555W at pH 7 (c) and pH 8 (d) before heating (black) and after heating to 70 °C (red) and cooling back to 20 °C 
(blue). (e,f) Far UV CD spectra of the 4th_FAS1 domains of H572R a pH 7.0 (e) and pH 8.0 (f) before heating 
(black) and after heating to 70 °C (red) and cooling back to 20 °C (blue). The WT and the mutants did not 
display any significant changes in structure at pH 7.0 and pH 8.0.
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conformation. This demonstrates that the β -oligomers were stable to thermal changes and at physiological con-
ditions allowing for further examination.
Cytotoxicity of β-oligomers. The toxicity of the β -oligomers on primary human corneal stromal fibro-
blast (pHCSF) cells was monitored using xCELLigence system. The WT domain did not interfere with the cell 
adhesion and proliferation and exhibited little or no toxic effect on the seeded cells (Fig. 8a). R555W also dis-
played no cytotoxicity. H572R, however, displayed higher cytotoxicity (**P < 0.01) on the fibroblasts compared 
to R555W (Fig. 8b). Interestingly, β -oligomers from both R555W and H572R were cytotoxic (**P < 0.01). While, 
the β -oligomers of R555W decreased the cell proliferation and the cytotoxic effect was visible after 12 hours, 
the β -oligomers of H572R displayed the maximum cytotoxic effect as no proliferation was observed and the 
xCELLigence showed minimum cell index. These results suggest that amyloidogenic mutant displayed significant 
cytotoxic effect both in the native as well as in the β -oligomeric forms whereas the non-amyloidogenic mutant 
was cytotoxic in the β -oligomeric form only. To obtain detailed information on the cytotoxicities, we prepared 
the β -oligomers of the two mutants at various acidic pH (pH 3.0, pH 4.5, pH 5.5). We also included the insoluble 
Figure 3. Thermal denaturation of the 4th_FAS1 domains of the WT and mutants at acidic pH. (a–c) Far 
UV CD spectra of the 4th_FAS1 domain of WT at pH 3.0 (a), pH 4.5 (b) and pH 5.5 (c) before heating (black) 
and after heating to 70 °C (red) and cooling back to 20 °C (blue). (d–f) Far UV CD spectra of the 4th_FAS1 
domain of R555W at pH 3 (d), pH 4.5 (e) and pH 5.5 (f) before heating (black) and after heating to 70 °C (red) 
and cooling back to 20 °C (blue). (g–i) Far UV CD spectra of the 4th_FAS1 domain of H572R at pH 3.0 (g), pH 
4.5 (h) and pH 5.5 (i) before heating (black) and after heating to 70 °C (red) and cooling back to 20 °C (blue). 
While the WT did not show any changes in structure, both the mutants displayed a very clear transition to 
β -sheet under acidic conditions.
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aggregates obtained after centrifuging the mildly precipitated samples. When we examined this precipitates using 
CD, we found similar β -sheet curves as we found for the soluble oligomers (data not shown). Hence, we investi-
gated these “insoluble aggregates” along with the soluble β -oligomers. The populations were reconstituted to pH 
7 using buffer exchange. pHCSFs from 3 different donors (n = 3) were treated with the β -oligomers and examined 
(Fig. 8c). The WT shows almost no cytotoxicity, similar to the control. The soluble β -oligomers derived from 
both the mutants at various acidic pH conditions displayed potent cytotoxic effect (**P < 0.01) compared to the 
insoluble aggregates and controls. The insoluble aggregates were also cytotoxic (*P < 0.05) but were relatively 
lesser compared to the soluble β -oligomers. The results were also validated using an MTT assay (Fig. 8d). Similar 
to xCELLigence, we could see that soluble β -oligomers derived from both the mutants displayed potent cytotoxic 
effect (**P < 0.01) compared to the controls and insoluble aggregates.
Discussion
The most significant aspect of the TGFβ Ip associated corneal dystrophies is that the single amino acid substi-
tutions in the mutants are responsible for clinically distinct phenotypes. Here, we examined the properties of 
Figure 4. Difference in thermal denaturation induced transition between non-amyloidogenic and 
amyloidogenic mutants at acidic pH. (a–e) Variable temperature CD curves at 222 nm of WT (black), R555W 
(red) and H572R (blue) proteins heated from 20 °C to 70 °C at various pH (3.0 [a], 4.5 [b], 5.5 [c], 7.0 [d] and 8.0 
[e]) and the CD intensities at 222 nm were plotted as a function of temperature. The baseline subtracted curves 
of the WT (black), R555W (red) and H572R (blue) proteins show that while there was no transition observed 
in the WT in all the conditions as observed from the unchanged straight line in black, little or no changes were 
seen in pH 7 and pH 8 for the mutants. However, clear transitions to β -sheet were observed at acidic pH (pH 3, 
pH 4.5 and pH 5.5) for both the mutants. In all cases, we observe transition (Tt) is higher for R555W compared 
to H572R. A clear shift in their thermal denaturation curves between the mutants at acidic pH (pH 3.0, 4.5 and 
5.5) is observed. A difference in Tt of 5–12 °C is observed at various pH conditions.
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two mutants, the amyloidogenic H572R22,23, and non-amyloidogenic R555W24–26. Previous attempts to study the 
differences between the WT and the mutants at physiological conditions have revealed minimal information on 
the mechanism of their aggregation38. To elucidate the inherent variations between these mutants, we examined 
the effects of various biophysical and biochemical factors like temperature and pH on them. In amyloid forming 
proteins such as β -microglobulin39, thermal unfolding leads to formation of β -oligomers. Results from our ther-
mal denaturation studies show clear differences between both the phenotypes and the WT protein at acidic pH.
Our results suggest that changes in the physiological pH can influence the biochemical and biophysical char-
acteristics of TGFβ Ip mutants. A clear conversion from α /β -structure to β -sheet was observed when the mutants 
were heated under acidic conditions (< pH 5.5). TEM and DLS studies confirmed the formation of β -oligomers 
by both phenotypes that remain irreversible and stable at physiological pH and temperature. For the first time 
we have shown that both the amyloidogenic and non-amyloidogenic phenotypes displayed marked differences 
Figure 5. pH sensitivity and stability of the non-amyloidogenic (R555W) phenotype. (a) Fluorescence 
emission spectra of R555W with decrease in pH. There was a clear decrease in emission maximum at 332 nm 
with decrease in pH (indicated by the black arrow). (b–e) Fluorescence emission spectra of R555W showing 
the reversibility to folded state after removal of urea. The R555W mutant was incubated with increasing 
concentrations of urea from 0.25 M to 8 M at various acidic conditions (pH 3, pH 4.5, pH 5.5) and pH 7 and 
the emission fluorescence before and after urea incubation was measured. The emission spectra before urea 
incubation 332 nm (black), after incubating with 8 M urea (red) and after removing urea by buffer exchange 
(blue). Unfolding of the protein is seen by the shifting of peaks (black arrow) from 332 nm to ~ 352 nm. The 
refolding of the protein after removal of urea is seen by the return of the emission maximum to ~332 nm (green 
arrow). (f–i) Investigation of the stability the non-amyloidogenic phenotype using urea denaturation studies. 
The R555W mutant was incubated with increasing concentrations of Urea from 0.25 M to 8 M at various acidic 
pH (pH 3, pH 4.5, pH 5.5) and pH 7, and the emission fluorescence was measured. The denaturation plots 
of ‘fraction unfolded vs urea concentration’ were plotted and fit into a two state model, with the parameters 
calculated as described in the methods section.
pH ΔGH2OZ, kJ/mole Cm, M m, kJ/mole/M
ΔΔGH2O , 
kJ/mole
3.0 8.417 ± 1.03 4.2 ± 0.15 3.14 ± 0.32 − 5.383
4.5 7.108 ± 1.5 4.74 ± 0.91 1.85 ± 0.25 − 6.692
5.5 11.28 ± 2.02 3.93 ± 0.21 2.78 ± 0.48 − 2.52
7.0 13.8 ± 0.8 3.09 ± 0.1 3.8 ± 0.3 –
Table 2.  Urea denaturation studies of the non-amyloidogenic phenotype. The R555W 4th FAS1 domain 
was incubated with increasing concentrations of urea from 0.25 M-8 M at various acidic pH conditions and the 
emission fluorescence was measured. The free energies at various pH conditions were calculated and tabulated.
www.nature.com/scientificreports/
9Scientific RepoRts | 6:23836 | DOI: 10.1038/srep23836
Figure 6. Characterization amyloidogenic and non-amyloidogenic β-oligomers. (a–b) Transmission 
Electron Microscopy. TEM images of the β -oligomers of the 4th_FAS1 domains of R555W (a) and H572R (b) 
mutants were acquired with a JEOL JEM-1010 transmission electron microscope using Digital Micrograph™  
1.81.78 for GMS 1.8.0. The β -oligomers of the amyloidogenic phenotype were larger measuring between 
10–40 nm, mean size ~19.1 nm ± 4.9 nm (a) compared to the non-amyloidogenic β -oligomers that measured 
4–8 nm, with a mean size ~5.1 nm ± 1.79 nm (b). Inset figures – particle size distribution of the β -oligomers. 
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in their sensitivities to pH and β -oligomer formation. The two β -oligomers of different phenotypes exhibit varia-
tions in their morphologies, sizes, thermal and chemical stabilities, aggregation patterns and cytotoxicity.
Supporting our results that acidic pH could play an important role in the aggregation of proteins in vivo, some 
recent studies have provided insights on the possible influence of acidic pH on the aggregation of proteins40–42. 
Pfefferkorn et al., have reported that Pmel 17, a functional amyloid involved in the structural scaffolding for 
melanin deposition in human skin and eyes, displays a strong tendency to form fibrils at acidic pH 5.0 43. The 
Pmel 17 fibrils are formed inside the melanosomes, organelles related to lysosomes that have acidic environments 
similar to lysosomes. Also, in studies involving TGFβ Ip associated dystrophies, Kim et al., have reported31 that 
the R124H mutation in TGFβ Ip disrupts its binding to periostin and causes TGFβ Ip to localize in lysosomes. It 
is well known that the lysosomal environment is highly acidic. While the mutation affects the binding of TGFβ Ip 
to its functional partners, the localization of TGFβ Ip mutants to the lysosomes with acidic pH could possibly 
induce the initiation of β -oligomer formation. While the 4th_FAS1 domain is not known to bind to periostin, it 
is still distributed to lysosomes by the R124H mutation31. It is known that the proteolytic fragments in patient 
samples include the 4th_FAS1 domain along with the 1st FAS1 domain44. Acidic environments could probably 
induce the conversion to β -sheet in the 4th_FAS1 domain. We also speculate that under acidic pH, binding of 
TGFβ Ip to periostin might be disrupted possibly due to the formation of β -oligomers in the presence of other 
interacting factors. TGFβ Ip is known to interact with several extracellular matrix proteins like various types of 
collagen, biglycan, decorin and fibronectin31 and it is possible that the acidic pH could probably have a disruptive 
effect on the binding of the mutants to other ECM components. Therefore, it is reasonable to suggest that acidic 
environments could play an important role in the aggregation of dystrophic mutants. At physiological conditions 
(pH 7.0), there were no perturbations in structure from the native conformation. Under acidic conditions (pH 
5.5 and below), we were able to show the ability of the mutants to form β -oligomers. Any change in the stromal 
environment causing a lowering of pH to about 1.5 units could probably be a trigger to initiate the formation of 
β -oligomers. Physiological events like lysosomal membrane disruption that can alter the pH values of the intra-
cellular and extracellular microenvironment by a pH reduction of ~1.5 (pH 7 → pH 5.5) during cellular processes 
such as wound-healing and phagocytosis45–47 could possibly lead to conversion to β -sheet and possibly formation 
of β -oligomers.
We performed long-term incubation of the WT and mutants in acidic pH conditions and followed their pos-
sible aggregation/oligomerization using ThT fluorescence and CD. Both the mutants did not display any aggre-
gation/oligomerization over 1 week (Supplementary Fig. S1). We also performed seeded fibrillation experiments 
using β -oligomers as seeds and incubated them for 2 weeks. However, we did not observe any significant increase 
in ThT fluorescence (Supplementary Fig. S4) within the period. There could be other cellular factors and inter-
acting molecules involved directly or indirectly with the aggregation that need to be studied along with the acidic 
pH at physiological temperature to induce aggregation/oligomerization. Prolonged incubation under these con-
ditions could probably induce the formation of oligomerization in both the cases. Also, in diseases conditions, 
patients harbor the mutations from birth, but the ages of onset range from few years to few decades. While we 
emphasize the significance of acidic pH in the possible aggregation and β -oligomer formation of the 4th_FAS1 
domain, we certainly believe that more detailed in vivo investigation is needed to delineate the aggregation mech-
anism and the molecules.
At neutral pH, we have seen that the R555W mutant is more stable than the WT. This was also seen in the 
stability experiments by Runager et al.48. However, from our results we see that the non-amyloidogenic R555W 
displays high susceptibility to acidic pH. In R555W, the mutation (R→ W) causes an overall reduction in net 
charge from − 0.6 to − 1.6 at pH 7.0 (17, Fig. 1c). At pH 5.5, the charge reduces from 1.9 to 0.9 17. The substitution 
of the hydrophobic tryptophan (− 2.13) in place of the polar arginine (3.95) also increases the hydrophobicity, 
thereby altering the solubility and possible folding of the mutant protein The reduction in charge coupled with 
the increase in hydrophobicity might influence the sensitivity of R555W to acidic pH. In H572R, the histidine 
residue is replaced by arginine residue. Histidine has a neutral charge at pH 7 and positive charge at acidic pH 
(pH < 6.0). While there is an increase in the overall charge from − 0.6 to 0.2 by the substitution of arginine at pH 
7, there is almost no change in the overall net charge for the H572R mutant under acidic conditions (1.9 to 2.0 at 
pH 5.5). This may explain the relatively higher stability of the H572R mutation at lower pH when compared to 
R555W. One of the important observations is the relative instability or sensitivity of R555W (pI 6.32) to pH 4.5. 
Our results from pH incubation studies, urea denaturation studies show that around pH 4.5, there is a decrease in 
While the amyloidogenic β -oligomers were larger and displayed rugged edges and varying diameters, the 
non-amyloidogenic β -oligomers were smaller in size with smoother edges and were more homogenous. 
(c) ThT assay. Emission fluorescence intensities at 485 nm recorded after incubating the WT TGFβ Ip and 
the β -oligomers of R555W and H572R with ThT dye. An amyloid forming peptide (611-633aa - pN622K) 
of TGFβ Ip was used as the positive control. The β -oligomers of the amyloidogenic mutant H572R showed 
significant fluorescence intensity (**P < 0.01) almost 3 times more fluorescence compared to the non-
amyloidogenic R555W. (d) DLS. %intensity plots plotted against the apparent hydrodynamic radii (RH).  
The RH values calculated from the distribution curves for R555W (~39.58 nm|pH 3.0, ~51.9 nm|pH 4.5 and 
~68.2 nm|pH 5.5) and H572R (~89.95 nm|pH 3.0, ~69 nm|pH 4.5 and ~155 nm|pH 5.5) show that H572R b-oligomers 
are larger in size and slightly more heterogeneous. (e,f) Mass Spectrometric analyses - Identification of the 
aggregation hotspots in the mutants and β -oligomers. (d) Peptide map generated following the insilico trypsin 
digestion of TGFβ Ip displaying a series of peptides. (e) The β -oligomers formed from the mutant 4th_FAS1 
domains were digested with trypsin and the resulting fragments were analyzed by LC–MS/MS. The regions 
inaccessible for trypsin digestion have been underlined in red. It is clearly seen that the non-amyloidogenic 
R555W shows more regions inaccessible for trypsin digestion.
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Figure 7. Stability of the β-oligomers at physiological conditions. (a–d) Thermal stability. Variable 
temperature CD values at 222 nm of the 4th_FAS1 domains of R555W (a) and H572R (c) in buffer at pH 5.5 
when heated from 20 °C to 70 °C. Far UV CD spectra of the 4th_FAS1 domains of R555W (b) and H572R 
(d) after heating (red) to 70 °C and cooling (blue) back to 20 °C. (e,f) Stability at physiological pH. Far UV 
CD spectra of the 4th_FAS1 domains (black) of R555W (e) and H572R (f) at pH 5.5 under native conditions 
(black), after heating to 70 °C (red) and after reconstituting in buffer at pH 7.0 (blue) after incubation at room 
temperature for 4 weeks.
www.nature.com/scientificreports/
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stability for R555W. Further characterization of R555W at pH 4.5 might provide more details on the significance 
of this pH.
It was also important to understand relative instability of R555W from a structural perspective. In recent 
studies, (Runager et al.48 and Underhaug et al.49) have observed that the R555W mutant is more stable than the 
WT48 and the 4th_FAS1 domain of R555W has a more compact structure49 at pH 7. Underhaug et al. also observed 
that the α 3′ helix, harboring the Arg555 residue, shows an increase in connected surface of negative charge in the 
R555W mutant compared to the WT which might directly influence its charged molecular interactions. They also 
found that in the presence of acidic conditions (10% TFE) R555W mutant exhibits higher aggregation propensity 
Figure 8. Cytotoxicity. (a) The growth and proliferation of the pHCSF cells following the treatment with the 
β -oligomers and the mutant 4th_FAS1 domains monitored for 48 hours in an xCELLigence system. (b) The cell 
survival after treatment for 24 hours plotted as area under the curve (AUC). While the WT and R555W show 
low cytotoxicity, almost similar to the media control, the amyloidogenic H572R mutant was cytotoxic compared 
to the control (**P < 0.01). Interestingly, the β -oligomers of both the amyloidogenic and non-amyloidogenic 
mutants showed high cytotoxicity (**P < 0.01) with the approximately 7 times more for the non-amyloidogenic 
mutant and 12 times more for the amyloidogenic mutant. To obtain detailed information on the cytotoxicity 
of the soluble and insoluble fractions, β -oligomers of the two mutants were prepared at various acidic pH 
conditions (pH 3.0, pH 4.5, pH 5.5) and their cytotoxicity were examined on pHCSFs from 3 different donors 
(n = 3) using xCELLigence (c) and MTT assays (d). (c) xCELLigence assay. The WT shows low cytotoxicity, 
almost similar to the control. The soluble β -oligomers of both the mutants showed high cytotoxicity (**P < 0.01) 
compared to the controls. The insoluble β -oligomers were relatively less cytotoxic compared to the soluble 
β -oligomers. (d) MTT assay. The cytotoxicity of the β -oligomers was also tested using an MTT assay. Similar to 
xCELLigence, we could see that soluble β -oligomers derived from both the mutants displayed potent cytotoxic 
effect (**P < 0.01) compared to the controls and insoluble aggregates. Though the insoluble oligomers were 
relatively less cytotoxic than the soluble oligomers, they displayed cytotoxicity compared to the controls.
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compared to the WT. The increased concentration of negative charges on the molecular surface of the R555W 
4th_FAS1 domain could possibly explain its sensitivity to acidic pH and also its instability at pH 4.5.
Various protein aggregation diseases involve β -oligomeric intermediates50–52. These β -oligomers could poten-
tially act as seeds for the formation of amyloid fibrils53,54, and hence understanding the stability of β -oligomers 
becomes vital. In our study, the β -oligomers from both the phenotypes formed at pH 5.5 remain stable at phys-
iological conditions for more than 4 weeks. Interestingly, the two β -oligomers seem to adopt different modes 
of oligomerization and also exhibit differences in their sizes, ThT-binding and cytotoxicity. Pfefferkorn et al.43, 
have shown in Pmel 17 that one of the first steps in fibril formation is the formation of β -oligomers that appear 
as large laterally associated small fibrillar species. At pH 4.5–5.0, a mix of amorphous and fibrillar structures 
were observed. Consistent with this, we have seen formation of β -oligomers that appear as spherical structures 
with rugged edges of different sizes using TEM. The amyloidogenic H572R displays larger particles compared 
to the non-amyloidogenic R555W. Previous studies in protein aggregation disorders like Parkinson’s syndrome 
have shown that the β -oligomers are more toxic than the amyloid fibrils themselves53–55. This has however not 
been studied in TGFBI-associated corneal dystrophies. When we assessed the cytotoxicity of the β -oligomers in 
pHCSF, β -oligomers from amyloidogenic H572R were more cytotoxic than the non-amyloidogenic R555W. In 
serum amyloid A (SAA) peptides55, the pathogenic and non-pathogenic strains appear as two distinct oligomeric 
populations (SAA1.1 and SAA2.2). While the non-pathogenic SAA2.2 forms smaller oligomers and grows into 
braided fibrils, the pathogenic SAA1.1 forms larger oligomers and grows into straight fibrils. Similar to this, the 
larger β -oligomers from amyloidogenic H572R are more cytotoxic compared to the smaller β -oligomers of the 
non-amyloidogenic R555W.
We have seen that the soluble β -oligomers of both mutants were more cytotoxic compared to the insoluble 
aggregates. This leads us to believe that while the soluble β -oligomers are responsible for cell death in the corneal 
dystrophies, the insoluble aggregates are more responsible for scattering of light and hence loss of visual acuity. 
This could also mean that cytotoxicity due to β -oligomer formation precedes the loss of sight due to accumula-
tion of protein aggregates. This provides us an important understanding in studying the modes of treatments of 
corneal dystrophies wherein, the hastening of the intermediary soluble β -oligomers to form insoluble and stable 
higher order aggregates such as fibrils and granules, could minimize cell death.
In conclusion, these results suggest that changes in the pH may cause localized perturbations in the sec-
ondary structure of the mutant proteins and increase the propensity to form β -oligomers. We have shown that 
under similar biophysical and biochemical conditions, the different mutant phenotypes exhibit differences in 
morphology, size and cytotoxicity. However, we did not observe the conversion of β -oligomers into amyloid fibrils 
even after incubation for 4 weeks. The soluble β -oligomers exhibit higher cytotoxicity compared to the insoluble 
β -oligomers. The interaction of β -oligomers with other extracellular matrix proteins will shed light into the mech-
anism of amyloid formation in future studies.
Methods
Materials. The cDNA constructs of the 4th_FAS1 domains of the WT TGFβ Ip, the mutants R555W and 
H572R were bought from Genscript (Piscataway, NJ) in pUC57 vectors. E.coli BL21(DE3) expression competent 
cells, Ek/LIC cloning kit and pCDF-2 vector system were purchased from Novagen (Novagen (EMD), PA). High-
performance Ni-Sepharose resin was purchased from GE Healthcare (GE healthcare Life Sciences, NJ). Amicon 
Centriprep filter units were purchased from EMD Millipore (EMD Millipore, MA). Ampicillin, streptomycin, iso-
propyl β -D-thiogalactopyranoside (IPTG) and Thioflavin T were purchased from Sigma-Aldrich (Sigma-Aldrich 
Inc., MO). Formvar-carbon coated nickel grids were bought from EMS (Electron Microscopy Sciences, PA).
Cloning, Protein expression and purification. Recombinant 4th_FAS1 domains of the WT, H572R and 
R555W TGFβ Ip proteins were cloned, expressed and purified as described previously21. Briefly, the TGFBI genes 
were cloned in pCDF2 vectors and expressed in E.coli BL21DE3 cells. The proteins were purified by affinity chro-
matography using a manually prepared column with High Performance Ni-sepharose beads. Further purification 
was done using RP-HPLC (C4 column, Phenomenex) with a linear gradient of 50% acetonitrile in 0.01% trifluo-
roacetic acid at a flow rate of 3 ml/min. The purified proteins were lyophilized and stored in − 20 °C.
Far-UV Circular Dichroism spectropolarimetry. Far UV–CD spectra of the proteins were collected 
using a Jasco J-810 spectropolarimeter (Jasco Inc., Easton, MD) using a quartz cuvette with a path length of 
0.1 cm (Hellma, Müllheim, Germany). Purified 4th_FAS1 WT and mutant TGFβ Ip proteins were reconstituted in 
buffers of varying pH (pH 3.0–8.0) to a final concentration of ~0.6 mg/ml (~37 μM) and their CD spectra were 
recorded.
For thermal denaturation experiments, the samples in buffers of varying pH (pH 3.0, pH 4.5, pH 5.5, pH 7.0 and 
pH 8.0) were heated from 20 °C to 70 °C at a rate of 1 °C/min using the inbuilt Peltier heating system. Thermal dena-
turation experiments were also performed by heating the samples from 20 °C–90 °C under the same conditions. 
The spectra were recorded from 260 nm to 190 nm with a step-size of 0.1 nm, at a scan rate of 50 nm/min for every 
2 °C. Variable temperature (VT) scanning was done by heating the sample to 70 °C at a rate of 1 °C/min and meas-
uring the ellipticity at 222 nm. Initial and final spectra before and after heating were recorded. The final spectrum 
was the average of three scans. The CD data were expressed as mean residual weight ellipticity (deg cm2 dmol-1). 
The mean residual weight (MRW) ellipticity ([θ ]MRW) was estimated using the equation
θ = θ × × ×λ l c[ ] [ ] MRW/10 [1]MRW
where [θ ]λ is the observed ellipticity, MRW is mean residual weight and defined as M/N− 1 where M is the molecu-
lar mass and N is number of amino acid residues, l is the path length of the cuvette and c is concentration in mg/ml. 
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The data obtained were fit into a two-state model using Origin 8.0 software and analysed using previously 
reported methods56–58.
For thermal stability experiments, the samples were heated to 70 °C and cooled back to 20 °C at a rate of 1 °C/min 
and the corresponding ellipticities at 222 nm were recorded. Far UV-CD spectra of the samples before heating, 
after heating to 70 °C and after cooling back to 20 °C were recorded. To test the effects of temperature ramping 
rates on the thermal unfolding, the mutant proteins were heated at pH 5.5, at various rates of thermal ramping 
(0.5 °C/min, 1 °C/min, 2 °C/min and 10 °C/min) and the CD spectra were recorded. VT curves were generated by 
measuring and plotting the CD intensity at 222 nm from 20 °C–70 °C.
For testing the stability of the β -oligomers at pH 7, the β -oligomers were formed by heating the mutants at 
pH 5.5, to 70 °C. Far UV-CD spectra after heating were recorded for the samples. The heated samples were cen-
trifuged at 14,600 rpm (~20,000 g) and reconstituted in PBS buffer at pH 7.0 and kept at room temperature for 
4 weeks and their CD spectra were recorded.
Fluorescence spectroscopy. The 4th_FAS1 domain of R555W was incubated at various acidic conditions 
(pH 3, pH 4.5, pH 5.5 and pH 7.0) and the emission spectra from 300 to 400 nm were recorded following excita-
tion at 280 nm for each sample using the Quanta Star spectrofluorimeter (Photon Technology International, NJ) 
using a 10 mm quartz cuvette. For urea denaturation studies, the R555W mutant protein (0.6 mg/ml – 37 μM) was 
treated with 0.25 M to 8 M urea for 16 hours at 4 °C. The intrinsic fluorescence corresponding to the tryptophan 
residue in R555W was measured as described above. To confirm the reversibility of the urea denatured proteins 
to their native conformation after removal of urea, the R555W protein was first incubated in buffers of different 
pH (pH 3.0, pH 4.5, pH 5.5 and pH 7.0) with 8 M urea for 24 hours. The unfolding of the proteins in the presence 
of 8 M urea was confirmed using fluorescence spectroscopy. These unfolded proteins were then reconstituted in 
buffers without urea by buffer exchange by centrifugation using Amicon Centriprep filter units. The emission 
peaks were measured. Reversibility studies were performed by diluting the R555W domain from 8 M urea to 
appropriate concentrations.
The denaturation data were fitted by non-linear least squares method, assuming a two state model59. To cal-
culate the thermodynamics parameters from the chemical denaturation data, we first plotted the emission fluo-
rescence spectra of the R555W mutant subjected to unfolding with 8 M urea. After confirming the shift in peaks 
from ~332 nm to ~ 352 nm, the differences in the wavelengths
∆λ = λ − λ (2)max max1 max2
corresponding to the emission peaks were plotted against urea concentration to estimate the λ U (unfolded) and 
λ F (folded). The fraction-folded
= λ − λ λ − λy ( )/( ) (3)F F U F
and fraction-unfolded
= λ − λ λ − λy ( )/( ) (4)U U U F
were calculated. The ΔG values were calculated by substituting values in the equation
∆ =G RT ln(y /y ) (5)F U
The resulting ΔG values from the linear range were plotted against urea concentration. The Y-intercept of the 
resulting straight line was taken as ΔGH2O and the slope (m) was estimated.
∆∆ = ∆ − ∆ ..G G G (6)H O at given pH H O at given pH H O at pH 7 02 2 2
Transmission Electron Microscopy (TEM). TEM images of the β -oligomers prepared at pH 5.5 were 
acquired with a JEOL JEM-1010 transmission electron microscope using Digital Micrograph™ 1.81.78 for GMS 
1.8.0 (Gatan, Pleasanton, CA) in the National University of Singapore Electron Microscopy facility. The samples 
were centrifuged and applied on Formvar-carbon coated nickel grids with bacitracin as the binding agent and 
negatively stained with 10% phosphotungstic acid (PTA). The samples were dried and observed at magnifications 
8000–50000X at 80 kV. The size of the particles were estimated using the relation,
= .Real size Measured length/Magnification
Thioflavin T assay. The native and heated domains were treated with 30 μM thioflavin T (ThT) in PBS 
buffer at pH 5.5 in a Greiner 96-well flat bottom polystyrol microplate (Greiner, Frickenhausen Germany). 
The samples were excited at 445 nm and the resulting emission fluorescence at 485 nm was measured using a 
microplate reader (Tecan infinite M200 pro, Zanker Road, SJ). The emission fluorescence was monitored for 
24 hours. A 20-amino acid long peptide (pN622K) from the 4th_FAS1 domain of TGFβ Ip with the mutation 
N622K (EPVAEPDIMATKGVVHVITNVLQ) capable of forming amyloid fibrils was used as positive control.
The native and heated 4th_FAS1 domains of the WT, R555W and H572R were incubated in buffers of dif-
ferent pH (pH 2.75, pH 3.25, pH 4.0, pH 4.5, pH 5.5 and pH 7.0) along with 30 μM thioflavin T (ThT) and their 
corresponding changes in fluorescence intensity at 485 nm were measured for a period of 7 days using the Tecan 
microplate reader. The N622K peptide was used a positive control.
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Seeded fibrillation studies were performed by treating the domains with their respective β -oligomers prepared 
at pH 5.5 using thermal denaturation as described above. The samples were shaken in an orbital shaker at 37 °C 
at 180 rpm. The samples were taken after 2 weeks and mixed with ThT for a final concentration of 30 μM and the 
fluorescence intensities were measured as described before.
Dynamic light scattering (DLS). The β -oligomers were formed by heating the 4th_FAS1 domains of the 
R555W and H572R in buffers of different pH (pH 3.0, pH 4.5, pH 5.5) to 70 °C. The buffers were filtered using a 
0.2 μM syringe filter before the thermal denaturation experiments. These prepared samples were examined using 
a DynaPro Plate ReaderII (Wyatt Technology, CA, US) equipped with a Peltier temperature controller. Each sam-
ples was measured 3 times and the average of the 3 scans is reported. The average and standard deviation values 
of the sizes corresponding to the peak of interest in each of these 3 distributions provides the apparent hydrody-
namic radius and the experimental error for each samples respectively.
Mass spectrometric analysis. The native and heated 4th_FAS1 domains of the WT, R555W and H572R 
were digested with trypsin. The tryptic-digested peptides were analyzed by LC–MS/MS [Ultimate 3000 nanoLC 
(Thermo Fisher Scientific/Dionex, Sunnyvale, CA), coupled with AB SCIEX Triple TOF TM 5600 mass spectrom-
eter]. The peptide mixture was first desalted and pre-concentrated in a trap column (Acclaim PepMap 100 C18, 
75 μm × 3 μm, 100 Å from Thermo Fisher Scientific/Dionex) for 3 min at a flow rate of 5 μl/min. After desalting, 
the system was switched into line with the reversed phase analytical capillary column (25 cm × 75 μm i.d. Acclaim 
PepMap RSLC C18, 2 μm, 100 Å, Thermo Fisher Scientific/Dionex, Sunnyvale, CA). A 35 min gradient was used 
at 300 nl/min. All data was acquired using information-dependent acquisition (IDA) mode with Analyst TF 1.5.1 
software (AB Sciex, USA). Protein Pilot software (version 4.01, AB Sciex) was used to analyze the MS/MS data.
Cytotoxicity. The xCELLigence system (ACEA, San Diego, CA, USA) was used to investigate the effects of 
the β -oligomers on pHCSF proliferation and cell death. Their E-plate 96 is incorporated with sensor arrays at the 
bottom of each well, which detects and translate cell attachment in the form of electronic impedance. A parameter 
termed cell index (CI) is derived which corresponds to the relative density and adherence strength of cells in each 
well60. pHCSF were seeded at a density of 5000 cells per well on an E-plate 96, in fibroblast media with 5% FBS. An 
initial concentration of ~37 μM (0.6 mg/ml) of the mutant protein was subjected to thermal denaturation at acidic 
pH to generate the β -oligomers. The β -oligomers were mixed with DMEM media at a ratio of 1:1 (~18 μM/0.3 mg/
ml final concentration) and added to pHCSF cells. Culture was maintained for 48 hours in the xCELLigence 
RTCA SP Station, placed in an incubator at 37o  C with 5% CO2. No media change was done to reduce the fluctua-
tions generated from removal of plate from RTCA system. The area under the curve (AUC) values were calculated 
from the cI values using the Mathematics module in OriginPro software and were used for further analysis.
To examine the cytotoxicities of the soluble and insoluble fractions in the β -oligomers, the β -oligomers of 
the two mutants prepared at various acidic pH conditions (pH 3.0, pH 4.5, pH 5.5) were were centrifuged at 
14,600 rpm (~20,000 g) to separate the insoluble fractions. The insoluble β -aggregates in the pellets were recon-
stituted in PBS buffers of pH 7.0. For the soluble β -oligomers in the supernatant, buffer exchange by centrif-
ugation using Amicon centriprep was done with PBS at pH 7.0. The soluble and insoluble populations were 
added to pHCSF cells from 3 donors (n = 3) and was monitored in an xCELLigence system. Cell survival assay 
using the xCELLigence system was performed as explained earlier. To test the cell viability, MTT assay was per-
formed in parallel. The cells were incubated with the β -oligomers for 48 hours and treated with MTT (3-(4,5-dim
ethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and incubated for 4 hours. The resulting color change was 
measured using the Tecan microplate reader (Tecan infinite M200 pro, Zanker Road, San Jose, USA).
Statistics. All numeric data obtained were expressed as mean ± standard deviation. For both the ThT bind-
ing assays and cytotoxicity studies using xCELLigence, all the comparisons were done using one-way ANOVA 
followed by post-hoc Bonferroni test (SPSS Statistics 22.0, IBM, Chicago, IL) for multiple comparisons. For both 
the experiments, values were deemed to be significant (*) when a significance level with a p-value of less than 
0.05 was achieved and very significant (**) when a significance level with a p-value of less than 0.01 was achieved.
References
1. Weiss, J. S. et al. The IC3D classification of the corneal dystrophies. Cornea 27 (Suppl. 2) S1–S83 (2008).
2. Klintworth, G. K. Corneal dystrophies. Orphanet J. Rare Dis. 4, 7 (2009).
3. Surguchev, A. & Surguchov, A. Conformational diseases: looking into the eyes. Brain Res. Bull 81, 12–24 (2010).
4. Lakshminarayanan, R. et al. Biochemical properties and aggregation propensity of transforming growth factor-induced protein 
(TGFβ Ip) and the amyloid forming mutants. Ocul Surf. 13(1), 9–25 (2015).
5. Kitahama, S. et al. Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone 
27, 61–67 (2000).
6. Ferguson, J. W. et al. The extracellular matrix protein betaIG-H3 is expressed at myotendinous junctions and supports muscle cell 
adhesion. Cell Tissue Res. 313, 93–105 (2003).
7. Escribano, J., Hernando, N., Ghosh, S., Crabb, J. & Coca-Prados, M. cDNA from human ocular ciliary epithelium homologous to 
beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium. J. Cell. Physiol. 160, 511–521 (1994).
8. Skonier, J. et al. beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell 
attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol. 13, 571–584 (1994).
9. Mashima, Y. et al. Severe form of juvenile corneal stromal dystrophy with homozygous R124H mutation in the keratoepithelin gene 
in five Japanese patients. Br J Ophthalmol. 82, 1280–1284 (1998).
10. Okada, M. et al. Granular corneal dystrophy with homozygous mutations in the kerato-epithelin gene. Am J Ophthalmol. 126, 
169–176 (1998).
11. Kannabiran, C. & Klintworth, G. K. TGFBI gene mutations in corneal dystrophies. Human Mutation 27 615–625 (2006).
12. Aldave, A. J. & Sonmez, B. Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet? Arch Ophthalmol. 
125, 177–186 (2007).
www.nature.com/scientificreports/
1 6Scientific RepoRts | 6:23836 | DOI: 10.1038/srep23836
13. Lakshminarayanan, R. et al. Structure-Function Relationship of TGFβ Ip (BIGH3) Associated Mutants in Corneal Dystrophy. Brit. 
J. Ophthalmol. 95(10), 1457–62 (2011).
14. Ołdak, M. et al. Late-onset lattice corneal dystrophy without typical lattice lines caused by a novel mutation in the TGFBI gene. 
Cornea 33(3), 294–9 (2014).
15. Klintworth, G. K., Valnickova, Z. & Enghild, J. J. Accumulation of beta ig-h3 gene product in corneas with granular dystrophy. Am 
J Pathol 152, 743–748 (1998).
16. Klintworth, G. K., Bao, W. & Afshari, N. A. Two mutations in the TGFBI (BIGH3) gene associated with lattice corneal dystrophy in 
an extensively studied family. Invest Ophthalmol Vis Sci. 45, 1382–8 (2004).
17. Chiti, F., Stefani, M., Taddei, N., Ramponi, G. & Dobson, C. M. Rationalization of the effects of mutations on peptide and protein 
aggregation rates. Nature 424(6950), 805–8 (2003).
18. Yuan, C., Berscheit, H. L. & Huang, A. J. Identification of an amyloidogenic region on keratoepithelin via synthetic peptides. FEBS 
Lett 581, 241–247 (2007).
19. Schmitt-Bernard, C. F. et al. BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. Eur J 
Biochem 269, 5149–5156 (2002).
20. Clout, N. J. & Hohenester, E. A model of FAS1 domain 4 of the corneal protein beta(ig)-h3 gives a clearer view on corneal 
dystrophies. Mol Vis 9, 440–448 (2003).
21. Elavazhagan, M. et al. Expression, purification and characterization of fourth FAS1 domain of TGFβ Ip-associated corneal 
dystrophic mutants. Protein Expr Purif. 84(1), 108–15 (2012).
22. Atchaneeyasakul, L. O. et al. Study Group. A novel H572R mutation in the transforming growth factor-beta-induced gene in a Thai 
family with lattice corneal dystrophy type I. Jpn J Ophthalmol. 50(5), 403–8 (2006).
23. Romero, P., Moraga, M. & Herrera, L. Different phenotypes of lattice corneal dystrophy type I in patients with 417C > T (R124C) 
and 1762A > G (H572R) mutations in TGFBI (BIGH3). Mol Vis. 16, 1601–9 (2010).
24. Munier, F. L. et al. BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci. 43, 949–954 (2002).
25. Fujiki, K., Nakayasu, K. & Kanai, A. Corneal dystrophies in Japan. J Hum Genet 46, 431–435 (2001).
26. Chakravarthi, S. V. V. K., Kannabiran, C., Sridhar, M. S. & Vemuganti, G. K. TGFBI gene mutations causing lattice and granular 
corneal dystrophies in Indian patients. Invest Ophthalmol Vis Sci 46, 121–125 (2005).
27. Dighiero, P. et al. Clinical, histologic, and ultrastructural features of the corneal dystrophy caused by the R124L mutation of the 
BIGH3 gene. Ophthalmology 107(7), 1353–7 (2000).
28. Kocak-Altintas, A. G., Kocak-Midillioglu, I., Akarsu, A. N. & Duman, S. BIGH3 gene analysis in the differential diagnosis of corneal 
dystrophies. Cornea 20(1), 64–8 (2001).
29. Wu, J. W. et al. Comparative analysis of human γ D-crystallin aggregation under physiological and low pH conditions. PLoS One. 12, 9(11) (2014).
30. Noormägi A., Valmsen K., Tõugu V. & Palumaa P. Insulin Fibrillization at Acidic and Physiological pH Values is Controlled by 
Different Molecular Mechanisms. Protein J. 2015 Oct 22 [Epub ahead of print].
31. Kim, B. Y. et al. Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization 
to the lysosome. J Biol Chem. 284(29), 19580–91 (2009).
32. Andreasen, M. et al. Polymorphic fibrillation of the destabilized fourth fasciclin-1 domain mutant A546T of the Transforming 
growth factor-β -induced protein (TGFBIp) occurs through multiple pathways with different oligomeric intermediates. J Biol Chem. 
287(41), 34730–42 (2012).
33. Ahmad B., Winkelmann J., Tiribilli B. & Chiti F. Searching for conditions to form stable protein oligomers with amyloid-like 
characteristics: The unexplored basic pH. Biochim Biophys Acta. 1804(1), 223–34 (2010).
34. Campioni, S. et al. Conformational properties of the aggregation precursor state of HypF-N. J Mol Biol. 379(3), 554–67 (2008).
35. Biancalana, M. & Koide, S. Molecular mechanism of thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta. 1804, 
1405–1412 (2010).
36. Groenning, M. Binding mode of thioflavin T and other molecular probes in the context of amyloid fibrils. Current status. J. Chem. 
Biol. 3, 1–18 (2010).
37. Maezawa, I. et al. Congo red and thioflavin-T analogs detect Abeta oligomers. J Neurochem. 104(2), 457–68 (2008).
38. Grothe, H. L. et al. Altered protein conformation and lower stability of the dystrophic transforming growth factor beta-induced 
protein mutants. Mol Vis. 19, 593–603 (2013).
39. Sasahara, K., Yagi, H., Naiki, H. & Goto, Y. Heat-induced Conversion of β 2-Microglobulin and Hen Egg-white Lysozyme into 
Amyloid Fibrils J. Mol. Biol. 372, 981–991 (2007).
40. Cardoso, I. et al. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled 
transthyretin amyloid-like fibrils. J Mol Biol 317, 683–95 (2002).
41. Smith, D. P., Jones, S., Serpell, L. C., Sunde, M. & Radford, S. E. A systematic investigation into the effect of protein destabilisation 
on beta 2-microglobulin amyloid formation. J Mol Biol 330, 943–54 (2003).
42. Aso, Y., Shiraki, K. & Takagi, M. Systematic analysis of aggregates from 38 kinds of non disease-related proteins: identifying the 
intrinsic propensity of polypeptides to form amyloid fibrils. Biosci Biotechnol Biochem 71, 1313–21 (2007).
43. Pfefferkorn, C. M., McGlinchey, R. P. & Lee, J. C. Effects of pH on aggregation kinetics of the repeat domain of a functional amyloid, 
Pmel17. Proc Natl Acad Sci USA 107(50), 21447–52 (2010).
44. Karring, H. et al. Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal 
human cornea during postnatal development and aging. Exp Eye Res. 90(1), 57–62 (2010).
45. Brunk, U. T. & Ericsson, J. L. Cytochemical evidence for the leakage of acid phosphatase through utrastructurally intact lysosomal 
membranes. Histochem J 4, 479–491 (1972).
46. Schneider, L., Korber, A., Grabbe, S. & Dissemond, J. Influence of pH on wound-healing: a new perspective for wound 
therapy ? Archives of Dermatological Research 298, 413–420 (2007).
47. Huynh, K. K. & Grinstein, S. Regulation of vacuolar pH and its modulation by some microbial species. Microbiol Mol Biol Rev. 71, 
452–462 (2007).
48. Runager, K. et al. Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of 
TGFBIp. J. Biol Chem. 286(7), 4951–8 (2011).
49. Underhaug, J. et al. Mutation in transforming growth factor beta induced protein associated with granular corneal dystrophy type 1 
reduces the proteolytic susceptibility through local structural stabilization. Biochimica et Biophysica Acta 1834, 2812–2822 (2013).
50. Klein, W. L., Krafft, G. A. & Finch, C. Targeting small Aβ oligomers: the solution to an Alzheimer’s disease conundrum? Trends 
Neurosci. 24, 219–224 (2001).
51. Ferreira, S. T., Vieira, M. N. & De Felice, F. G. Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid 
diseases. IUBMB Life 59, 332–345 (2007).
52. Volles, M. J. & Lansbury, P. T. Jr. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson’s disease-linked 
mutations and occurs by a pore-like mechanism. Biochemistry 41(14), 4595–602 (2002).
53. Sokolov, Y. et al. Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure. J Gen Physiol. 128(6), 
637–47 (2006).
54. Valincius, G. et al. Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: 
implications for cell toxicity. Biophys J. 95(10), 4845–61 (2008).
www.nature.com/scientificreports/
17Scientific RepoRts | 6:23836 | DOI: 10.1038/srep23836
55. Srinivasan, S. et al. Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly 
amyloidogenic non-pathogenic SAA2.2. J Biol Chem. 288(4), 2744–55 (2013).
56. Pace, C. N. & Sholtz, J. M. Protein Structure: A Practical Approach (Creighton T. E. ed) pp. 299–321, IRL Press, Oxford, UK.
57. Benjwal, S., Verma, S., Rohm, K. H. & Gursky, O. Monitoring protein aggregation during thermal unfolding in circular dichroism 
experiments. Protein science: a publication of the Protein Society 15, 635–9 (2006).
58. Bullock, A. N. et al. Thermodynamic stability of wild-type and mutant p53 core domain. Proc Natl Acad Sci USA 94, 14338–42 (1997).
59. Pace, C. N. & Shaw, K. L. Linear extrapolation method of analyzing solvent denaturation curves. Proteins Suppl 4, 1–7 (2000).
60. Urcan, E. et al. Real-time xCELLigence impedance analysis of the cytotoxicity of dental composite components on human gingival 
fibroblasts. Dental Materials 26, 51–58 (2010).
Acknowledgements
The authors would like to thank Dr. Gary Yam for his helpful insights. The project was funded by NMRC 
Singapore (CS-IRG grant R978/87/2012).
Author Contributions
E.M., L.R. and J.S.M. conceived the experiments and wrote the paper. E.M. cloned the genes, expressed the 
proteins, performed the CD fluorescence, TEM experiments and prepared the oligomers for MS experiments 
and cytotoxicity studies. A.V., V.M. and N.M. assisted in the expression and purification of the proteins. Z.L. 
performed the MS experiments. N.M. and E.G. assisted with the CD experiments on thermal denaturation. 
R.R.Y.L., G.S.L.P. and S.S.C. performed the cytotoxicity assays. R.W.B. and S.S.C. provided inputs to the 
conception of the work and editing the article.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Murugan, E. et al. pH Induced Conformational Transitions in the Transforming 
Growth Factor β-Induced Protein (TGFβIp) Associated Corneal Dystrophy Mutants. Sci. Rep. 6, 23836; doi: 
10.1038/srep23836 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
